Literature DB >> 1325861

Ontogenesis and binding properties of high-affinity neurotensin receptors in human brain.

N Zsürger1, J Chabry, A Coquerel, J P Vincent.   

Abstract

The ontogenesis of neurotensin binding sites was studied in human brain of subjects deceased from Sudden Infant Death Syndrome. Monoiodo-Tyr3 neurotensin specifically recognized 2 distinct classes of binding sites in human brain homogenate. The high affinity sites were already present at birth and increased to a maximal level of 240 fmol/mg protein 1 month after birth. Thereafter, the density of these sites decreased to reach a value of 8 fmol/mg protein in 15-month-old brain, a value similar to that found in adult brain. The dissociation constant of the high-affinity sites (about 0.3 nM) did not vary from birth to adulthood. The high-affinity binding sites were sensitive to GTP which decreased their affinity for neurotensin by a factor of 3, indicating that these sites are functional receptors coupled to GTP-binding proteins. By contrast, the low-affinity sites were insensitive to GTP and could be partly blocked by the antihistaminic drug levocabastine. These sites were absent in human brain during the first post-natal year and could be detected only in brain homogenate of 15-month-old infants. The transient increase in high-affinity neurotensin binding sites after birth suggests that neurotensin could act as a regulatory peptide during brain development.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325861     DOI: 10.1016/0006-8993(92)91640-z

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Neurotensin receptors: binding properties, transduction pathways, and structure.

Authors:  J P Vincent
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

2.  IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin.

Authors:  Irene Tsilioni; Arti B Patel; Harry Pantazopoulos; Sabina Berretta; Pio Conti; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-07       Impact factor: 11.205

3.  Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.

Authors:  D Gully; M Canton; R Boigegrain; F Jeanjean; J C Molimard; M Poncelet; C Gueudet; M Heaulme; R Leyris; A Brouard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

4.  Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain.

Authors:  J Mazella; J M Botto; E Guillemare; T Coppola; P Sarret; J P Vincent
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

5.  Chromosomal localization of mouse and human neurotensin receptor genes.

Authors:  P Laurent; P Clerc; M G Mattei; P Forgez; X Dumont; P Ferrara; D Caput; W Rostene
Journal:  Mamm Genome       Date:  1994-05       Impact factor: 2.957

6.  Expression of a rat neurotensin receptor in Escherichia coli.

Authors:  R Grisshammer; R Duckworth; R Henderson
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

7.  Neurotensin and its receptors in the control of glucose homeostasis.

Authors:  Jean Mazella; Sophie Béraud-Dufour; Christelle Devader; Fabienne Massa; Thierry Coppola
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-26       Impact factor: 5.555

Review 8.  The Role of Central Neurotensin in Regulating Feeding and Body Weight.

Authors:  Jariel Ramirez-Virella; Gina M Leinninger
Journal:  Endocrinology       Date:  2021-05-01       Impact factor: 4.736

9.  Developmental dynamics of neurotensin binding sites in the human hypothalamus during the first postnatal year.

Authors:  Mohamed Najimi; Alain Sarrieau; Nicolas Kopp; Fatiha Chigr
Journal:  Front Cell Neurosci       Date:  2014-09-10       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.